Get access

Cognitive impairment and dementia in Parkinson's disease

Authors

  • Karen Marder MD, MPH

    Corresponding author
    1. Departments of Neurology, Columbia University, New York, New York, USA
    2. Department of Psychiatry, Columbia University, New York, New York, USA
    3. Sergievsky Center, Columbia University, New York, New York, USA
    4. Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, USA
    • 630 W. 168th St., Unit 16, New York, NY 10032
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

Abstract

Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based on demographic, neurological, neuropsychological, imaging, and genetic investigations have been delineated. The FDA has approved a treatment for PDD, and efforts now are directed toward intervention at earlier stages of cognitive impairment. © 2010 Movement Disorder Society

Get access to the full text of this article

Ancillary